The management of Elephant's Ear poisoning

2001 ◽  
Vol 20 (4) ◽  
pp. 189-192 ◽  
Author(s):  
D Tagwireyi ◽  
D E Ball

The Araceae family of plants is the major cause of symptomatic plant ingestions in some developed countries (Dieffenbachia and Philodendron) and in Zimbabwe (Elephant's Ear), especially in children. A retrospective case series was carried out to evaluate the management of poisoning due to Elephant's Ear at the largest referral hospital in Zimbabwe for the period January 1995-December 1999. The study revealed inappropriate use of antibiotics, atropine, and antihistamines in the treatment of Elephant's Ear poisoning. This article also reviews the management of poisoning due to the Araceae family of plants as exemplified by Elephant's Ear. There is a need to educate health care workers on the clinical management of Elephant's Ear poisoning especially in developing countries where there are limited resources.

2021 ◽  
pp. 100896
Author(s):  
Abeera Ahmed ◽  
Fatima Sana ◽  
Aamer Ikram ◽  
Shagufta Yousaf ◽  
Aysha Khan

2020 ◽  
Vol 2 (2) ◽  
pp. 125-133
Author(s):  
Zayani Zohari ◽  
Variant Nee Vern Chee ◽  
Li Yen Chan ◽  
Jamalia Rahmat

Neonatal retinoblastoma is more widely reported in developed countries than in developing countries. We have conducted a retrospective case series to understand the nature of neonatal retinoblastoma in Malaysia due to lack of data from developing countries. A retrospective record review of 295 patients was conducted from the Retinoblastoma Registry on the National Eye Database (NED) between January 2005 and December 2019. Six out of 295 patients (2.03%) were identified as neonatal retinoblastoma in Malaysia from 2005 until 2019 compared to developed countries, in which the detection rate were 3.5 to 10 times higher. Lack of awareness among survivor parents about the risk of their newborns developing retinoblastoma in may be a contributing factor. Neonatal retinoblastoma is difficult to manage, thus close and continuous monitoring is needed in centres dedicated to retinoblastoma management.


2018 ◽  
Vol 124 ◽  
pp. 279-283 ◽  
Author(s):  
Divakar Sharma ◽  
Juhi Sharma ◽  
Nirmala Deo ◽  
Deepa Bisht

CHEST Journal ◽  
2017 ◽  
Vol 152 (4) ◽  
pp. A19
Author(s):  
Michelle Kam ◽  
Melvin Seng ◽  
Kenneth Choy ◽  
Keng Leong Tan

1992 ◽  
Vol 108 (1) ◽  
pp. 1-18 ◽  

Great strides have been made towards the control of poliomyelitis since the introduction of the two poliovaccines – inactivated poliovirus vaccine (IPV), which was licensed in the United States in 1954, and live attenuated oral poliovaccine (OPV), in 1961. Today a large majority of physicians and other health–care workers in industrialized countries never see a patient with paralytic poliomyelitis. Unfortunately, this is far from the situation in many developing countries, particularly in tropical and subtropical climates, where hundreds of thousands of children still become paralysed victims, year in and year out.


2021 ◽  
pp. 104803
Author(s):  
Souheil Zayet ◽  
Pierre-Yves Royer ◽  
Lynda Toko ◽  
Alix Pierron ◽  
Vincent Gendrin ◽  
...  

2017 ◽  
Vol 28 ◽  
Author(s):  
Evalyne Wambui Kanyina ◽  
Waqo Gufu Boru ◽  
Gerald Mburu Mucheru ◽  
Samuel Anyangu Amwayi ◽  
Tura Galgalo

Sign in / Sign up

Export Citation Format

Share Document